• Dr. Tariq Mahmood in the NHS Leeds and York Partnership Innovation newsletter. DrMahmoodLYRI



  • McGirr A, Lipina TV, Mun HS, Georgiou J, Al-Amri AH, Ng E, Zhai D, Elliott C, Cameron RT, Mullins JG, Liu F, Baillie GS, Clapcote SJ, Roder JC. Specific Inhibition of Phosphodiesterase-4B Results in Anxiolysis and Facilitates Memory Acquisition. Neuropsychopharmacology. 2015 Aug 14. doi: 10.1038/npp.2015.240.
  • Reichelt A, Dachtler J. The role of neurexins and neuroligins in autism. Book chapter in ‘The Molecular Basis of Autism’, 361-381. Springer.


  • Dachtler J, Glasper J, Cohen RN, Ivorra JL, Swiffen DJ, Jackson AJ, Harte MK, Rodgers RJ, Clapcote SJ. Deletion of α-neurexin II results in autism-related behaviors in mice. Transl Psychiatry. 2014 Nov 25;4:e484. doi: 10.1038/tp.2014.123.


  • Mahmood T, Cardno A, Nazar Q, Clapcote S, Inglehearn C (2013). Consanguinity multiplex and schizophreni-the royal road to genes of major effect. European Psychiatry Volume 28, Supplement 1, 2013, Pages 1.
  • Beetschen E, Tomlinson A, Harte M, Mahmood T, Neill JC (2013). Severe cognitive impairment within a multiply affected South Asian family with a high risk of schizophrenia.
  • Kirshenbaum GS, Dawson N, Mullins JG, Johnston TH, Drinkhill MJ, Edwards IJ, Fox SH, Pratt JA, Brotchie JM, Roder JC, Clapcote SJ. Alternating hemiplegia of childhood-related neural and behavioural phenotypes in Na+,K+-ATPase α3 missense mutant mice. PLoS One. 2013;8(3):e60141. doi: 10.1371/journal.pone.0060141.
  • Ritchie D, Clapcote S (2013). Disc1 deletion is present in Swiss-derived inbred mouse strains: implications for transgenic studies of learning and memory. Lab Anim. 2013 Apr 5.
  • Dachtler J, Watt N, Hooper N, Rodgers RJ, Clapcote SJ. Neurexin-2 knockout mice display autistic-like behavioral phenotypes and alterations in glutamatergic-related brain proteins. Society for Neuroscience Annual Meeting, San Diego, 2013.


  • Dachtler J, Rodgers RJ, Clapcote SJ (2012). Behavioural analysis of a C-terminal region DISC1 mutant mouse. Journal of Psychopharmacology, Conference Proceedings, Supp. to Vol 26, 8: A63.
  • Reichelt AC, Rodgers RJ, Clapcote SJ (2012). The role of neurexins in schizophrenia and autistic spectrum disorder. Neuropharmacology. 2012 Mar;62(3):1519-26. doi: 10.1016/j.neuropharm.2011.01.024. Review.